2022 tables: Institutions - life sciences - corporate

The 2022 tables are based on Nature Index data from 1 January 2021 to 31 December 2021.

Table criteria

# Institution Share 2020 Share 2021 Count 2021 Change in Adjusted Share 2020-2021*
1 BGI, China 7.34 8.83 47 19.0%
2 Takeda Pharmaceutical Company Limited, Japan 2.16 6.12 18 180.2%
3 Formosa Plastics Group, Taiwan 6.00 4.25 19 -30.0%
4 Eisai Co., Ltd., Japan 0.23 3.03 6 1,206.0%
5 China Shipbuilding Industry Corporation (CSIC), China 0.73 1.84 39 149.7%
6 Sosei Co., Ltd., Japan 0.06 1.41 3 2,428.8%
7 FiberHome Technologies Group, China 0.37 1.38 16 272.1%
8 Innovent Biologics, Inc., China 1.13 2 N/A
9 Toyota Group, Japan 0.04 1.06 3 2,612.1%
10 Scohia Pharma Inc., Japan 1.00 1 N/A
11 China National Pharmaceutical Group (Sinopharm), China 0.70 0.92 2 30.4%
12 Geneplus-Beijing Institute, China 0.19 0.85 3 338.6%
13 WuXi AppTec, China 0.45 0.84 8 83.8%
14 National Institute of Water and Atmospheric Research Ltd. (NIWA), New Zealand 0.21 0.80 10 281.5%
15 China National Chemical Corporation (ChemChina), China 1.59 0.77 5 -52.0%
16 Seikagaku Corporation, Japan 0.20 0.75 1 270.6%
17 Ribomic Inc., Japan 0.73 2 N/A
18 Yakult Central Institute for Microbiological Research, Japan 0.73 1 N/A
19 Institute of Environmental Science and Research (ESR), New Zealand 0.40 0.71 3 74.0%
20 Guangzhou BeBetter Medicine Technology Co., LTD., China 0.71 1 N/A
21 Nippi. Inc., Japan 0.69 3 N/A
22 Samsung Group, South Korea 2.43 0.67 16 -72.8%
23 Tencent, China 0.60 0.65 5 6.3%
24 Livestock Improvement Corporation (LIC), New Zealand 0.65 1 N/A
25 HiFiBio Limited - China, China 0.62 2 N/A
26 Clover Biopharmaceuticals, Inc., China 0.60 1 N/A
27 Precision Scientific (Beijing) Co., Ltd., China 0.19 0.57 2 198.7%
27 Advanced Telecommunications Research Institute International (ATR), Japan 1.31 0.57 2 -57.4%
28 Gero Pte. Ltd., Singapore 0.56 1 N/A
29 ILIAS Biologics Inc., South Korea 0.25 0.55 1 113.2%
30 CSL Limited, Australia 0.22 0.53 4 134.4%
31 ABL Bio Inc., South Korea 0.52 1 N/A
32 ImmunoScape Pte. Ltd., Singapore 0.52 3 N/A
33 Kirin Holdings Company Limited, Japan 0.04 0.51 4 1,335.3%
34 Novogene Co., Ltd., China 0.84 0.50 6 -40.9%
35 Ajinomoto Co., Inc., Japan 0.45 0.50 1 11.0%
36 Celltrion Inc., South Korea 0.49 2 N/A
37 Tomocube, Inc., South Korea 0.20 0.45 2 122.3%
38 Thinkcyte Inc., Japan 0.45 1 N/A
39 Lifetech Scientific (Shenzhen) Co., Ltd., China 0.11 0.45 2 298.2%
40 aetherAI, Taiwan 0.44 1 N/A
41 Singlera Genomics Inc., China 0.47 0.44 3 -7.9%
42 Baidu Inc., China 0.02 0.43 1 2,187.0%
43 Sumitomo Dainippon Pharma Co., Ltd., Japan 0.26 0.41 2 55.3%
44 Dartsbio Pharmaceuticals Ltd., China 0.41 1 N/A
45 Astellas Pharma Inc., Japan 0.97 0.38 2 -60.9%
46 GeneOne Life Science, Inc., South Korea 0.38 1 N/A
46 Silexon AI Technology Co., Ltd., China 0.38 1 N/A
47 InnoTherapy, Inc., South Korea 0.36 1 N/A
48 KOTAI Biotechnologies, Inc., Japan 0.35 3 N/A
49 National Chengdu Center for Safety Evaluation of Drugs, China 0.06 0.33 1 474.0%
49 Livzon Pharmaceutical Group Inc., China 0.33 1 N/A
50 Shionogi & Co., Ltd., Japan 0.09 0.33 5 285.5%

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at nature.com/nature-index/.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2021 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.